Literature DB >> 15236410

Sequence-dependent and independent inhibition specific for mutant ataxin-3 by small interfering RNA.

Yi Li1, Takanori Yokota, Ryusuke Matsumura, Kazunari Taira, Hidehiro Mizusawa.   

Abstract

In Machado-Joseph disease (MJD) gene, there is a C/G polymorphism immediately after the CAG repeat; the expanded CAG repeat tract is exclusively followed by C, whereas about half of wild-type alleles are followed by G. Using this C/G polymorphism, we have engineered the small interfering RNA (siRNA) which decreased the expression of mutant ataxin-3, Q79C, by 96.0%, whereas there was minimal reduction on that of the wild type, Q22G (5.9%). Furthermore, unexpectedly, the expression of another wild-type allele, Q22C, was also much less suppressed (22.5%) by this siRNA possibly due to difference of the secondary structure of the target RNA. This is the first report of sequence-independent discrimination of mutant and wild-type alleles by siRNA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15236410     DOI: 10.1002/ana.20141

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  12 in total

Review 1.  Allele-selective inhibition of trinucleotide repeat genes.

Authors:  Masayuki Matsui; David R Corey
Journal:  Drug Discov Today       Date:  2012-01-18       Impact factor: 7.851

Review 2.  Spinocerebellar ataxia type 2: clinical presentation, molecular mechanisms, and therapeutic perspectives.

Authors:  J J Magaña; L Velázquez-Pérez; B Cisneros
Journal:  Mol Neurobiol       Date:  2012-09-21       Impact factor: 5.590

3.  Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3.

Authors:  Mercedes Prudencio; Hector Garcia-Moreno; Karen R Jansen-West; Rana Hanna Al-Shaikh; Tania F Gendron; Michael G Heckman; Matthew R Spiegel; Yari Carlomagno; Lillian M Daughrity; Yuping Song; Judith A Dunmore; Natalie Byron; Björn Oskarsson; Katharine A Nicholson; Nathan P Staff; Sorina Gorcenco; Andreas Puschmann; João Lemos; Cristina Januário; Mark S LeDoux; Joseph H Friedman; James Polke; Robin Labrum; Vikram Shakkottai; Hayley S McLoughlin; Henry L Paulson; Takuya Konno; Osamu Onodera; Takeshi Ikeuchi; Mari Tada; Akiyoshi Kakita; John D Fryer; Christin Karremo; Inês Gomes; John N Caviness; Mark R Pittelkow; Jan Aasly; Ronald F Pfeiffer; Venka Veerappan; Eric R Eggenberger; William D Freeman; Josephine F Huang; Ryan J Uitti; Klaas J Wierenga; Iris V Marin Collazo; Philip W Tipton; Jay A van Gerpen; Marka van Blitterswijk; Guojun Bu; Zbigniew K Wszolek; Paola Giunti; Leonard Petrucelli
Journal:  Sci Transl Med       Date:  2020-10-21       Impact factor: 17.956

4.  An evaluation of oligonucleotide-based therapeutic strategies for polyQ diseases.

Authors:  Agnieszka Fiszer; Marta Olejniczak; Pawel M Switonski; Joanna P Wroblewska; Joanna Wisniewska-Kruk; Agnieszka Mykowska; Wlodzimierz J Krzyzosiak
Journal:  BMC Mol Biol       Date:  2012-03-07       Impact factor: 2.946

5.  miRNA-Mediated Knockdown of ATXN3 Alleviates Molecular Disease Hallmarks in a Mouse Model for Spinocerebellar Ataxia Type 3.

Authors:  Rui Jorge Nobre; Diana D Lobo; Carina Henriques; Sonia P Duarte; Sara M Lopes; Ana C Silva; Miguel M Lopes; Fanny Mariet; Lukas K Schwarz; M S Baatje; Valerie Ferreira; Astrid Vallès; Luis Pereira de Almeida; Melvin M Evers; Lodewijk J A Toonen
Journal:  Nucleic Acid Ther       Date:  2021-12-07       Impact factor: 4.244

Review 6.  Oligonucleotide-based strategies to combat polyglutamine diseases.

Authors:  Agnieszka Fiszer; Wlodzimierz J Krzyzosiak
Journal:  Nucleic Acids Res       Date:  2014-05-21       Impact factor: 16.971

Review 7.  RNA interference: from gene silencing to gene-specific therapeutics.

Authors:  Ray K M Leung; Paul A Whittaker
Journal:  Pharmacol Ther       Date:  2005-08       Impact factor: 12.310

Review 8.  Small non-coding RNAs add complexity to the RNA pathogenic mechanisms in trinucleotide repeat expansion diseases.

Authors:  Eulàlia Martí; Xavier Estivill
Journal:  Front Mol Neurosci       Date:  2013-12-03       Impact factor: 5.639

9.  Influence of mismatched and bulged nucleotides on SNP-preferential RNase H cleavage of RNA-antisense gapmer heteroduplexes.

Authors:  Dorota Magner; Ewa Biala; Jolanta Lisowiec-Wachnicka; Ryszard Kierzek
Journal:  Sci Rep       Date:  2017-10-02       Impact factor: 4.379

10.  Inhibition of hepatitis C virus infection and expression in vitro and in vivo by recombinant adenovirus expressing short hairpin RNA.

Authors:  Naoya Sakamoto; Yoko Tanabe; Takanori Yokota; Kenichi Satoh; Yuko Sekine-Osajima; Mina Nakagawa; Yasuhiro Itsui; Megumi Tasaka; Yuki Sakurai; Chen Cheng-Hsin; Masahiko Yano; Shogo Ohkoshi; Yutaka Aoyagi; Shinya Maekawa; Nobuyuki Enomoto; Michinori Kohara; Mamoru Watanabe
Journal:  J Gastroenterol Hepatol       Date:  2007-08-07       Impact factor: 4.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.